PT869970E - Inibidor da proliferacao de celulas endoteliais e sua utilizacao - Google Patents

Inibidor da proliferacao de celulas endoteliais e sua utilizacao

Info

Publication number
PT869970E
PT869970E PT96945635T PT96945635T PT869970E PT 869970 E PT869970 E PT 869970E PT 96945635 T PT96945635 T PT 96945635T PT 96945635 T PT96945635 T PT 96945635T PT 869970 E PT869970 E PT 869970E
Authority
PT
Portugal
Prior art keywords
inhibitor
proliferation
utilization
endothelial cells
cell proliferation
Prior art date
Application number
PT96945635T
Other languages
English (en)
Inventor
Michael S O Reilly
Yihai Cao
Donald J Davidson
Moses Judah Folkman
Original Assignee
Childrens Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/763,528 external-priority patent/US5854221A/en
Application filed by Childrens Medical Center filed Critical Childrens Medical Center
Publication of PT869970E publication Critical patent/PT869970E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Medicines Containing Plant Substances (AREA)
PT96945635T 1995-12-13 1996-12-13 Inibidor da proliferacao de celulas endoteliais e sua utilizacao PT869970E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US851995P 1995-12-13 1995-12-13
US08/763,528 US5854221A (en) 1996-12-12 1996-12-12 Endothelial cell proliferation inhibitor and method of use

Publications (1)

Publication Number Publication Date
PT869970E true PT869970E (pt) 2004-08-31

Family

ID=26678280

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96945635T PT869970E (pt) 1995-12-13 1996-12-13 Inibidor da proliferacao de celulas endoteliais e sua utilizacao

Country Status (20)

Country Link
US (1) US20010016644A1 (pt)
EP (1) EP0869970B1 (pt)
JP (1) JP3684371B2 (pt)
KR (1) KR100477280B1 (pt)
CN (1) CN1554444A (pt)
AT (1) ATE262537T1 (pt)
AU (1) AU710612B2 (pt)
BR (1) BR9612115A (pt)
CA (1) CA2240296C (pt)
CZ (1) CZ298612B6 (pt)
DE (1) DE69631972T2 (pt)
DK (1) DK0869970T3 (pt)
ES (1) ES2217340T3 (pt)
HK (1) HK1017692A1 (pt)
HU (1) HUP9900979A3 (pt)
NO (1) NO321775B1 (pt)
NZ (1) NZ330537A (pt)
PL (1) PL188719B1 (pt)
PT (1) PT869970E (pt)
WO (1) WO1997023500A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0869970T3 (da) * 1995-12-13 2004-07-05 Abbott Lab Endothelcelleprolifereringsinhibitor og dens anvendelse
US6699838B1 (en) 1996-05-03 2004-03-02 Abbott Laboratories Antiangiogenic peptides
US5801146A (en) * 1996-05-03 1998-09-01 Abbott Laboratories Compound and method for inhibiting angiogenesis
WO1997041824A2 (en) * 1996-05-03 1997-11-13 Abbott Laboratories Antiangiogenic peptides derived from plasminogen
US5801012A (en) 1996-09-17 1998-09-01 Northwestern University Methods and compositions for generating angiostatin
EP1001985A1 (en) * 1997-06-26 2000-05-24 Karolinska Innovations AB Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo
AU1598599A (en) * 1997-11-20 1999-06-15 Genetix Pharmaceuticals, Inc. Anti-angiogenic gene therapy vectors and their use in treating angiogenesis-related diseases
US6632961B1 (en) 1998-05-22 2003-10-14 Abbott Laboratories Antiangiogenic drug to treat cancer, arthritis and retinopathy
EP1171582A2 (en) * 1999-05-17 2002-01-16 Conjuchem, Inc. Long lasting anti-angiogenic peptides
PT1180121E (pt) 1999-05-17 2004-03-31 Conjuchem Inc Peptidos insulinotropicos de longa duracao
US7144854B1 (en) 1999-09-10 2006-12-05 Conjuchem, Inc. Long lasting anti-angiogenic peptides
EP1242451A2 (en) * 1999-12-15 2002-09-25 EntreMed, Inc. Compositions and methods for inhibiting endothelial cell proliferation
EP1320545A2 (en) 2000-09-05 2003-06-25 Karolinska Innovations AB Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen
AU2002239414A1 (en) * 2000-11-02 2002-05-27 Bristol-Myers Squibb Company Modified plasminogen related peptide fragments and their use as angiogenesis inhibitors
EP2444805A3 (en) * 2004-01-21 2012-06-20 Fujirebio America, Inc. Detection of mesothelin-/megakaryocyte potentiating factor-related peptides in peritoneal fluid for assessment of the peritoneum and the peritoneal cavity
CN100355458C (zh) * 2005-03-16 2007-12-19 北京大学 人增殖抑制基因－腺病毒表达载体的应用
US20120220015A1 (en) 2009-05-26 2012-08-30 Biolex Therapeutics Compositions and methods for production of aglycosylated plasminogen
CN103060265B (zh) * 2013-01-23 2014-12-03 山东大学 老年大鼠脑血管内皮细胞原代培养方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929444A (en) * 1985-05-28 1990-05-29 Burroughs Wellcome Co. Low pH pharmaceutical formulation containing t-PA
US5149533A (en) * 1987-06-04 1992-09-22 Zymogenetics, Inc. Modified t-PA with kringle-/replaced by another kringle
US5302390A (en) * 1987-07-01 1994-04-12 Beecham Group Plc Hybrid proteins of human plasminogen and human t-PA, pharmaceutical compositions and methods of treatment
US5491129A (en) * 1992-07-30 1996-02-13 Yeda Research And Development Co. Ltd. Synthetic peptides derived from vitronectin and pharmaceutical compositions comprising them
AU2355895A (en) * 1994-04-26 1995-11-16 Pharmacia & Upjohn Company Mac-1 i-domain protein useful in blocking adhesion and migration of neutrophils
WO1995029242A1 (en) * 1994-04-26 1995-11-02 The Children's Medical Center Corporation Angiostatin and method of use for inhibition of angiogenesis
ES2292174T3 (es) * 1995-04-26 2008-03-01 The Children's Medical Center Corporation Fragmentos de angiostatina y procedimientos de utilizacion.
DK0869970T3 (da) * 1995-12-13 2004-07-05 Abbott Lab Endothelcelleprolifereringsinhibitor og dens anvendelse

Also Published As

Publication number Publication date
ATE262537T1 (de) 2004-04-15
CZ298612B6 (cs) 2007-11-21
PL327200A1 (en) 1998-11-23
US20010016644A1 (en) 2001-08-23
EP0869970A4 (en) 2002-01-30
AU710612B2 (en) 1999-09-23
DK0869970T3 (da) 2004-07-05
NO982715D0 (no) 1998-06-12
HK1017692A1 (en) 1999-11-26
EP0869970B1 (en) 2004-03-24
CA2240296C (en) 2004-05-04
WO1997023500A1 (en) 1997-07-03
KR19990072126A (ko) 1999-09-27
CA2240296A1 (en) 1997-07-03
NZ330537A (en) 2001-06-29
CZ182898A3 (cs) 1998-10-14
NO321775B1 (no) 2006-07-03
ES2217340T3 (es) 2004-11-01
HUP9900979A2 (hu) 1999-07-28
KR100477280B1 (ko) 2005-07-18
EP0869970A1 (en) 1998-10-14
DE69631972T2 (de) 2005-01-05
AU1687097A (en) 1997-07-17
BR9612115A (pt) 1999-02-17
HUP9900979A3 (en) 2001-10-29
JP3684371B2 (ja) 2005-08-17
NO982715L (no) 1998-08-12
CN1554444A (zh) 2004-12-15
DE69631972D1 (de) 2004-04-29
JP2002502359A (ja) 2002-01-22
PL188719B1 (pl) 2005-04-29

Similar Documents

Publication Publication Date Title
PT869970E (pt) Inibidor da proliferacao de celulas endoteliais e sua utilizacao
DE69433168D1 (de) In vitro vermehrung von stammzellen
ATE183196T1 (de) Peptidinhibitoren von fibronectin und verwandten kollagen-bindenden proteinen
DE69617583D1 (de) In vitrozellkultur-System
NZ330897A (en) Human trk receptors and neurotropic factor inhibitors
BR9707049A (pt) Agentes anticoagulantes utilizáveis no tratamento de trombose
DE69736669D1 (de) Zelladhäsionsinhibitoren
DE69231065D1 (de) Heparin-und sulfatid-bindende peptide vom typ 1 der wiederkehrenden sequenzen vom menschlichen thrombospondin
AU5754298A (en) Sandwich assays for collagen type i fragments
EP0675728A4 (en) MEANS AND METHODS FOR IMPROVING KERATINOYCTE ADHESION TO THE SKIN.
ATE191223T1 (de) Verwendung von zelladhäsions-peptiden zur modifikation des haftungsvermögens eukaryontischer zellen untereinander
SE9600742D0 (sv) Vridbart arrangemang
FI961584A0 (fi) C-reaktiivisista proteiinifragmenteista johdetut oligopeptidit
BR9407357A (pt) Novos tripeptideos utilizáveis em terapia cns e imune
MX9205978A (es) Nuevas proteinas inhibidoras de trombina de garrapatas.
DE69635457D1 (de) Deprenyl induziertes protein
MY106261A (en) Anti-inflammatory 1-heteroaryl oxindole-3-carboxamides.
DE69530779D1 (de) Muramylpeptide zusammensetzungen für inhibierung von hiv replikation
TR199801495T2 (xx) Vinil s�lfoksitler ve sentezlenmeleri i�in bir i�lem.
ECSP972005A (es) Agentes anticoagulantes utiles en el tratamiento de trombosis
RU95114125A (ru) Ингибитор пролиферации стволовых кроветворных клеток